Skip to Content
Merck
All Photos(1)

Key Documents

H6508

Sigma-Aldrich

Heparin−Agarose

Type I, saline suspension

Synonym(s):

Heparin beads, Heparin resin

Sign Into View Organizational & Contract Pricing


About This Item

MDL number:
UNSPSC Code:
23151817
NACRES:
NA.56

biological source

heparin from Porcine intestinal mucosa

Quality Level

type

Type I

form

saline suspension

extent of labeling

400-1500 μg per mL packed gel (activity approx. 140 USP units per mg)

technique(s)

affinity chromatography: suitable

matrix

cross-linked 4% beaded agarose

matrix activation

cyanogen bromide

matrix attachment

amino

matrix spacer

1 atom

suitability

suitable for chromatography

storage temp.

2-8°C

Looking for similar products? Visit Product Comparison Guide

Application

Heparin-agarose is developed from porcine intestinal mucosa and is used in affinity chromatography. Heparin-agarose has been used in studies to provide information on human monocytic ehrlichiosis, tumor necrosis and the effects of coagulation from Vipera snake venom.

Physical form

Suspension in 0.5 M NaCl containing preservative

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

I V Kaplan et al.
Atherosclerosis, 158(2), 455-463 (2001-10-05)
Oxidation of beta-lipoproteins has been linked to the development of arteriosclerosis. Using a copper mediated cell free system to oxidize beta-lipoproteins, we found that beta -lipoproteins isolated from plasma were less susceptible to oxidation than lipoproteins from serum and that
M E Silvestri et al.
Scandinavian journal of immunology, 53(3), 282-289 (2001-03-17)
An investigation was performed into the heparin-binding properties of a synthetic peptide deduced from the sequence of human cytomegalovirus glycoprotein B. The peptide, T7-13:3, amino acids 69-78, which was previously shown to contain a neutralization epitope was able to bind
Analysis of Adeno-Associated Virus and HPV Interaction.
Hermonat, P.L., et al.
Methods in Molecular Medicine, 119, 397-409 (2006)
91. Universal purification of AAV serotypes 1?5 modified to contain a heparin binding epitope.
Faust, S.M., et al.
Molecular Therapy, 9, S36-S36 (2004)
G Glaser et al.
Archives of virology, 143(10), 1967-1983 (1998-12-18)
The immediate early BRLF1 and BZLF1 promoters of Epstein-Barr virus are crucial for triggering the replicative cycle of the virus. To better understand the cell type dependence of the lytic cycle we conducted an analysis of the BRLF1-promoter in the

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service